Publications

Publications EFEMERIS

Tramadol During Pregnancy: Risk of Adverse Pregnancy Outcome and Major Congenital Anomalies. A Comparative Study in the EFEMERIS Database. Ferrer E, Delteil L, Caillet A, Karam F, Lacroix I. Pharmacoepidemiol Drug Saf. 2025 Apr

The EFEMEREYE Study: prenatal medication exposure and ocular anomaly occurrence in EFEMERIS health database. J AAPOS., 2024

Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database. J Clin Psychiatry, 2023.

First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database. Infection, 2022.

Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: comparative study in the EFEMERIS database. Mycoses, 2022.

From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding. Clin Pharmacol Ther., 2022.

Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss - An observational study using the EFEMERIS database. Therapie, 2021.

What changes in prescription patterns of antiemetic medications in pregnant women in France? Fundam. Clin. Pharmacol., 2021.

Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database. Drug Saf., 2021.

Non-steroidal anti-inflammatory drug prescriptions from the 6th month of pregnancy: impact of advice from health authorities. Fundam Clin Pharmacol., 2019.

In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database. Int J Pediatr Otorhinolaryngol., 2018.

Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort. Eur Arch Psychiatry Clin Neurosci., 2018.

A contemporary description of French newborns' growth using the Efemeris cohort. Arch Pediatr., 2017.

Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics. Drug Saf., 2017.

Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ, 2017.

Prescription of asthma medications before and during pregnancy in France: An observational drug study using EFEMERIS database. J Asthma, 2016.

Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database. Fundam Clin Pharmacol., 2016.

How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women? Pharmacoepidemiol Drug Saf., 2016.

First epidemiological data for venotonics in pregnancy from the EFEMERIS database. Phlebology, 2015.

Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database. Arch Gynecol Obstet., 2014.

Healthcare databases in Europe for studying medicine use and safety during pregnancy. Pharmacoepidemiol Drug Saf., 2014.

Drug in Pregnancy: Studies in the French Database EFEMERIS. Thérapie, 2014.

Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database. BJOG, 2014.

Pandemic A/H1N1 influenza vaccination during pregnancy: A comparative study using the EFEMERIS database. Vaccine, 2014.

Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication. Curr Drug Saf., 2012.

Can benfluorex induce congenital malformations? Diabetes Metabolism, 2012.

Drugs in pregnancy: study in the EFEMERIS database (2004 to 2008). Gynecol Obstet Fertil., 2011.

First epidemiologic data about phloroglucinol exposure during first trimester of pregnancy. Gynecol Obstet Fertil., 2011.

Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol., 2009.

EFEMERIS: une nouvelle base de données française. La Lettre du Pharmacologue, 2009.

Télécharger

Publications POMME

Prescriptions of respiratory medications in children aged 0-10 years: A longitudinal drug utilization study in the POMME database. Respir Med., 2024

Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study. Front Psychiatry., 2022.

POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure. Drug Saf., 2018

Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database. Br J Clin Pharmacol., 2016.

Risk of infections during the first year of life after in utero exposure to drugs acting on immunity: A population-based cohort study. Pharmacol Res., 2016

Autres publications de l'Unité

Identifying multiple sclerosis in women of childbearing age in six European countries: a contribution from the ConcePTION project. Eur J Epidemiol . 2025

Methods of estimating prevalence of multiple sclerosis in six European healthcare data sources: a contribution from the ConcePTION project. Eur J Epidemiol . 2025

Real-World Assessment of Psychotropic and Antiepileptic Drug Use During Pregnancy in Belgium: Trends, Predictors, and Comparative Risk of Congenital Anomalies (2010-2016) Pharmacoepidemiol. Drug Saf., 2024

Systematic review of gabapentinoid use during pregnancy and its impact on pregnancy and childhood outcomes: A ConcePTION study. Therapie., 2024

Prevalence of Congenital Ocular Anomalies in 15 Countries of Europe: Results From the Medikeye Study. Birth Defects Res., 2024

Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions Therapie., 2024

The first review on prenatal drug exposure and ocular malformation occurrence. Front Pediatr., 2024

Belgian medication exposure during pregnancy (BeMeP), a new nationwide linked database: Linkage methods and prevalence of medication usePharmacoepidemiol Drug Saf., 2024

The development of a core outcome set for studies of pregnant women with multimorbidity. BMC Med., 2023

Impact of therapeutic education on the evolution of social representations of medication in patients with Parkinson's disease: A quantitative and qualitative study (ETPARK REMED). Rev Neurol (Paris)., 2023

Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocol BMJ Open., 2023

Prevalence of polypharmacy in pregnancy: a systematic review. BMJ Open., 2023.

Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis. BMC Pregnancy Childbirth., 2023.

Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. BMC Med., 2023.

Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age? Therapie, 2023.

Trends and regional variations in prescriptions dispensed to stimulate uterine contractions at the end of pregnancy in Belgium: A community-based study from 2003 to 2018. Pharmacoepidemiol Drug Saf., 2023.

Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert. Int Breastfeed J., 2022.

COVID-19 in pregnancy-what study designs can we use to assess the risk of congenital anomalies in relation to COVID-19 disease, treatment and vaccination? Paediatr Perinat Epidemiol., 2022.

Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. BMC Pregnancy Childbirth, 2022.

Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians. Epilepsy Behav., 2022.

Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems. Drug Saf., 2021.

COVID-19 vaccines and pregnancy: What do we know? Therapie, 2021.

Maternal Medication Use and Childhood Cancer in Offspring-Systematic Review and Considerations for Researchers. Am J Epidemiol., 2021.

Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 2017. Pharmacoepidemiol Drug Saf., 2021.

Longitudinal Methods for Modeling Exposures in Pharmacoepidemiologic Studies in Pregnancy. Epidemiol Rev., 2021.

Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database. Therapie, 2020.

Chloroquine and hydroxychloroquine during pregnancy: What do we know? Therapie, 2020.

Use of triptans during pregnancy? With caution! Therapie, 2019.

Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries, EUROMEDISAFE consortium. Pharmacoepidemiol Drug Saf., 2019.

Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016, EUROMEDISAFE consortium. Pharmacoepidemiol Drug Saf., 2019.

Pharmacoepidemiology in pregnancy. Therapie, 2019.

Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiol Drug Saf., 2018.

Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties. Fundam Clin Pharmacol., 2018.

POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure. Drug Saf., 2018.

Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study. Br J Clin Pharmacol., 2018.

The importance of pharmacoepidemiology in pregnancy - Implications for safety. Expert Opin Drug Saf., 2017.

Risk of infections during the first year of life after in utero exposure to drugs acting on immunity: A population-based cohort study. Pharmacol Res., 2016.

Medication exposure and spontaneous abortion: a case-control study using a French medical database. Clin Exp Obstet Gynecol., 2015.

Use of calcium channel blockers (CCB) for tocolysis in France and abroad. J Gynecol Obstet Biol Reprod., 2015.

Analysis of chats on French internet forums about drugs and pregnancy. Pharmacoepidemiol Drug Saf., 2014.

Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database. Eur J Clin Pharmacol., 2014.

Ibuprofen does not seem to increase global malformation risk but NSAID use in late pregnancy remains a concern. Evid Based Med., 2014.

The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Saf., 2013.

Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: The results of a French prospective descriptive study. Vaccine, 2011.

Drug Prescribing Before and During Pregnancy in South West France : a retrolective study. Drug saf., 2011.

Contact

Publications EFEMERIS

Publications POMME

Autres publications de l'Unité